发明名称 Reduced volume formulation of glatiramer acetate and methods of administration
摘要 A method for reducing frequency of relapses in a human patient afflicted with relapsing-remitting multiple sclerosis (RRMS) comprising administering to the patient 0.5 ml of an aqueous pharmaceutical solution of 20 mg glatiramer acetate and 20 mg mannitol.
申请公布号 US9018170(B2) 申请公布日期 2015.04.28
申请号 US201012948611 申请日期 2010.11.17
申请人 Teva Pharmaceutical Industries, Ltd. 发明人 Altman Ayelet;Saltkill Doris;El-Gad Tomer;Tomlinson Dalton L.
分类号 A61K38/07;A61K9/00;A61K38/16 主分类号 A61K38/07
代理机构 Cooper & Dunham LLP 代理人 White John P.;Gershik Gary J.;Cooper & Dunham LLP
主权项 1. An aqueous pharmaceutical solution which is 0.5 ml in volume and contains 20 mg glatiramer acetate and 20 mg mannitol in water for injection.
地址 Petach-Tikva IL